Cell and Gene Outsourcing

  1. A Robust And Scalable Suspension Platform For AAV Manufacturing

    Review the demands for AAV manufacturing using a suspension process and the DOE-based strategy used to achieve a scalable process both in terms production and quality of AAV purified.

  2. Selecting Containers For Sensitive And Costly Cell & Gene Therapies

    Explore the challenges related to packaging of cell and gene therapy products and proven solutions to enable speed to market and compatibility, performance of packaging materials.

  3. Candidate Screening And Feasibility Studies For Viral Gene Therapies

    Create a simple, modular path to cGMP manufacturing that minimizes risk. Explore a strategic approach for early-stage development and how it can propel therapies to the clinic and the market.

  4. Optimizing Viability And Standardization For Clinical Excellence 10/2/2024

    Explore how IntegriCell™ delivers high-quality, manufacture-ready cryopreserved leukopaks, vital for consistent and reliable cell therapy production.

  5. An End-To-End Industrialization Roadmap For Autologous Cell Therapy

    Explore specificities and challenges, leveraging automation for scalability with the Cocoon® Platform, and building a vein-to-vein network to achieve ‘just-in-time’ delivery of therapies.

  6. AAV Analytics: Key Considerations When Developing A Clinical Program 4/25/2024

    Finding partners with the necessary skills to optimize AAV processes is crucial for minimizing risk. Explore key considerations for advancing your therapy from concept to commercialization.

  7. Mastering The Art Of Developing A Successful Bispecific Antibody 10/3/2024

    Learn innovative strategies to overcome the complexities of bispecific antibody development, from intelligent design to efficient purification techniques.

  8. Identify And Quantify AAV Fill States Using Analytical Ultracentrifugation 3/14/2024

    Explore how to implement analysis using sedimentation velocity analytical ultracentrifugation to characterize AAV size distributions and multiple detection wavelengths to identify various fill states in AAV preparation.

  9. Optimizing Monoclonal Antibody Manufacturing For Commercial Success

    Strategically optimize your upstream and downstream processes and decrease the timeline from optimization to commercial manufacturing.

  10. CRISPR Genome Editing Solutions From Discovery To Clinic

    Examine how a partnership leveraging expertise in production for high-quality CRISPR gRNAs as well as cGMP manufacturing is supporting the clinical translation of CRISPR genome editing technologies.